Course Ticket     

 

Every effort has been made to convert the EPA 2020 scientific programme into a fully virtual programme. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive programme. Please note that some presenters were not yet able to pre-record their presentations, therefore there are still some sessions with some missing presentations.

Browse 313 Sessions

Date
03.07.2020, Friday
Room
Meeting Room 1
Date
04.07.2020, Saturday
Room
Auditorium A
Session Session Pre Recorded Short Label
,
Date
04.07.2020, Saturday
Room
Auditorium A
Session Description
First introduced in 2015, the EPA Forum traditionally precedes the official opening of the annual European Congress of Psychiatry. The Forum brings together EPA members and congress delegates with European organisations, stakeholders and policy makers, in the field of mental health and mental health care, to present and discuss matters of European importance. The 2020 edition of the EPA Forum will see the active participation of the patient organisation GAMIAN-Europe (EPA Board member), in addition to different policy makers and mental health experts from the EU and international organisations working in the field of mental health. This year’s programme focuses on the consequences of the Covid-19 outbreak on mental health care, and its medium- and long-term impact on practices and collaboration between health and mental health work forces at the EU-level. Moreover, new to 2020, the EPA Forum will be broadcast live and offer all viewers to take an active role. Live polling will allow the audience to have its say on core issues raised during the event.
Session Session Pre Recorded Short Label
Date
04.07.2020, Saturday
Room
Berlin
Session Description
* This course requires pre-registration and a ticketEARLY INTERVENTION - A KEY FEATURE OF PSYCHIATRY IN THE FUTURE Mental illness is associated with high burden of disease and it has severe individual and societal consequences. It will be of immense value to be able to intervene in risk groups identified before onset of psychosis and other severe psychiatric disorders. In first episode psychosis, early Intervention services with team-based intensive case management and family involvement are superior to standard treatment in reducing psychotic and negative symptoms and comorbid substance abuse and improving social functioning and user satisfaction. As an introduction, the results of the OPUS-trial will be presented together with meta-analyses based on similar trials. The basic principles for working in an early intervention team will be presented and discussed. Involving families is a cornerstone in early intervention. Family involvement can be in many different formats, depending on the needs and preferences of the patients and the relatives. The multifamily group approach will be presented with vignettes and tried out in role plays. The implementation of OPUS all over Denmark will be presented together with the Danish OPUS-fidelity study.
Date
04.07.2020, Saturday
Room
Caracas/Bogota
Session Description
By 2017 UNHCR estimated that over 68.5 million persons were forcibly displaced due to wars, armed conflicts, persecution and human rights violations. Mental health problems that forcibly displaced people (refugees and asylum seekers) experience constitute a serious public mental health problem. There is increasing evidence that a large proportion of refugees and asylum seekers residing in Europe suffer from the consequences of traumatic events and exhibit mental disorders including, but not limited to, trauma related disorders, e.g., Post-Traumatic Stress Disorder. EPA considers as one of its major tasks to raise awareness on this important problem and outline strategies for how its member societies and the psychiatric profession at large may contribute to managing these challenges. This course aims to increase awareness, basic knowledge and skills of the psychiatrists and other mental health workers. The following issues will be addressed during this course: (i) basic nosology/terminology related to the forcibly displaced people (i.e., refugees, asylum seekers, IDPs, and etc.); (ii) facts and statistics on the current dimensions of problem; (iii) physical and psychological traumas, including sexual abuses, related to the displacement process; (iv) mental health situation and needs of specific risk groups among the forcibly displaced people; (v) current evidence on the mental health consequences and related psychiatric disorders; (vi) culturally sensitive clinical interview and assessment techniques; (vii) evaluation of the current situation of mental health care provision including a review of the opportunities and limits of existing mental health services for the forcibly displaced people.
Date
04.07.2020, Saturday
Room
Mexico
Session Description
Proposed by the EPA Section on Neurodevelopmental Disorders Across the Lifespan (NDAL)Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterised by persistent difficulties in social interaction and communication, as well as restricted interests, stereotypic behaviours and resistance to change. The prevalence of ASD in the general population is around 1%. The studies have shown that adults with ASD experience significant disadvantage in employment, social relationships, quality of life. But unfourtunately, adult providers having less knowledge of ASD, possible differences in ASD presentation in females, and inaccurate diagnosis due to misattribution of ASD symptoms to another psychiatric disorder. Another complex issue is the group of later-diagnosed adults, who sometimes is referred to as “the lost generation”, as they were children during a time when autism was more narrowly defined and thus were not identified when young. There is a real need to increase the knowledge of autism focused on adults, particularly on diagnosis and how best to support autistic individuals as they transition into and move through adulthood. The Neurodevelopmental Disorders Across Lifespan section of EPA proposes to organize a course on ASD in adults in order to improve the knowledge among clinicians and the quality of servicies for adults with ASD. We will organize 4 lectures with European experts on this topic , dividit in two blocks. The first block will include 1)Introduction to ASD and 2) Diagnosing ASD in adults. The second block will be centered on treatments, 3) Pharmacological treatment and 4) Psychological treatments. In each block we will have 30 minutes for practical cases and questions.
Date
04.07.2020, Saturday
Room
Buenos Aires
Session Description
The diagnostic interview remains at the heart of clinical psychiatric practice. It consist of a dialogue between two subjects with the common goal of clarifying symptoms and diagnosis. It is precisely within such dialogic setting that the manifold diversity of psychopathological phenomena emerges, often beyond the descriptive boundaries of diagnostic glossaries. Indeed, the interview is a vital prerequisite to treatment and invariably sets the tone for the therapeutic alliance. The course, which capitalizes on the personal experience as a service user of one of the co-directors, is built upon a combination of live patient interview, discussions and short lectures. It will address foundational aspects of the psychiatric interview, focusing on strategic-technical aspects and relational-empathic skills; and also provide concrete advices, tips and tricks from experienced interviewers and patients. Key learning points will be: 1. how to establish an atmosphere of interpersonal trust and to initiate the diagnostic process, 2. how to ask “the best questions”, 3. how to explore the meaning behind common language phrases like “I feel depressed” or “I have had a nervous breakdown”, 4. how to discriminate between normal”, morbid and psychotic; and between subjective experience, notions and expressed behavior. 5. how to choose the best diagnostic tools and instruments.
Date
04.07.2020, Saturday
Room
Berlin
Session Description
Ethics (from the Greek ‘εθiks: the best way to behave”) is, according to the Oxford dictionary “the branch of knowledge that deals with moral principals”. Moral principles govern a person’s behaviour. Aristotle held “virtues” as the guiding principal, Kant “duty”, whereas utilitarianism stipulates that the “guiding principal” should be “the greatest happiness or benefit of the greatest number”. In medicine ethics are based on the Hippocratic oath, nowadays expressed in the “Declaration of Geneva” (1948, revised 2006 in current revision to be finalized in October 2017). Two moral principles in this medical oath are crucial: - respect for the autonomy of the patient and their safety (in a broad sense: both physical and intellectual (privacy). In clinical practice, medical doctors struggle, on daily basis, with dilemmas around these themes. These themes will be explored and discussed in groups, using case vignettes in which doctors are confronted with ethical dilemmas. The course directors will propose a number of cases, but the participants will be encouraged in an interactive fashion to discuss their own experiences.
Date
04.07.2020, Saturday
Room
Caracas/Bogota
Session Description
Proposed by the EPA Section on Women, Gender and Mental Health.The management of childbearing mothers with mental illness is challenging, requiring the clinician to maintain maternal wellbeing during pregnancy, whilst preventing postnatal recurrences and avoiding harm to the child. The course will cover the use of antidepressants, antipsychotics, lithium, anti-epileptic drugs and sleep-inducers in pregnant and breastfeeding mothers. Recent evidence on potential teratogenic risks of these agents arising from early pregnancy exposure will be outlined as well as effects on obstetric and infant outcome following later pregnancy exposure. Adverse effects on neonatal health will be reviewed and the current knowledge on drug transfer from the mother to the infant during breastfeeding discussed. This evidence will be related to current pharmacological guidelines for childbearing women. An important consideration in the management of childbearing women is that risks to the child do not only arise from the use of psychotropic medication. There is increasing evidence that maternal mental illness by itself and associated lifestyle and social factors can alter infant outcomes. Although there are no optimal solutions, a thoughtful and informed approach to the evidence, consideration of the woman’s own history and preferences, and maximizing benefits of non-pharmacological treatment approaches can improve individual outcomes. Preconception consultations for women who have psychosis or severe mood disorders and are planning a pregnancy, are highlighted as a means of optimizing maternal and child outcomes.